Press release
Pharmacogenomics Technology & Theranostics & Companion Diagnostics Market Analysis, Overview, Share, Growth, Industry Segmentation | Valuates Reports
The global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market size is projected to reach USD 8514.8 Million by 2028, from USD 5180.8 Million in 2021, at a CAGR of 6.9% during 2022-2028.
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-12J1837/global-pharmacogenomics-technology-theranostics-companion-diagnostics-cdx
China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market size is valued at US$ million in 2021, while the North America and Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-12J1837/Global_Pharmacogenomics_Technology_Theranostics_Companion_Diagnostics_CDx
By Type
• PCR
• In-situ Hybridization
• Immunohistochemistry
• Sequencing
• Others
By Application
• Oncology
• Neurological Disorders
• Cardiovascular Disease
• Immunological Disorders
• Others
By Company
• Qiagen NV
• GE Healthcare
• Agilent Technologies
• F Hoffman La Roche
• Foundation Medicine
• Thermo Fisher Scientific Inc.
• Leica Biosystems Nussloch GmBH
• Pfizer
Inquire for Regional Data: https://reports.valuates.com/request/regional/QYRE-Auto-12J1837/Global_Pharmacogenomics_Technology_Theranostics_Companion_Diagnostics_CDx
Similar Reports:
1. Pharmacogenomics Market: https://reports.valuates.com/reports/QYRE-Auto-22U5750/global-pharmacogenomics-pgx
2. Pharmacovigilance Market: https://reports.valuates.com/reports/QYRE-Auto-13S3239/global-pharmacovigilance
3. Precision Medicine Market: https://reports.valuates.com/reports/QYRE-Auto-24M598/global-precision-medicine
4. Genetic Testing Market: https://reports.valuates.com/market-reports/ALLI-Auto-0I340/genetic-testing
5. Bioinformatics Market: https://reports.valuates.com/market-reports/ALLI-Auto-0B326/bioinformatics
6. Live Cell Imaging Market: https://reports.valuates.com/reports/INFO-Othe-4N51/live-cell-imaging
Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137
Email Id:
Please reach us at sales@valuates.com
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Technology & Theranostics & Companion Diagnostics Market Analysis, Overview, Share, Growth, Industry Segmentation | Valuates Reports here
News-ID: 2595475 • Views: …
More Releases from Valuates Reports
Underfills for Semiconductor Market Size, Revenue Share, Insights & Future Outlo …
Underfills for Semiconductor Market Size
The global market for Underfills for Semiconductor was valued at US$ 276 million in the year 2024 and is projected to reach a revised size of US$ 460 million by 2031, growing at a CAGR of 7.1% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic…
Embedded Substrate (ETS) Market Size, Revenue Share, Insights & Future Outlook
Embedded Substrate (ETS) Market Size
The global market for Embedded Substrate (ETS) was valued at US$ 1242 million in the year 2024 and is projected to reach a revised size of US$ 2182 million by 2031, growing at a CAGR of 8.5% during the forecast period.
According to our Semiconductor Research Center, in 2022, the global semiconductor materials was valued at US$ 70.3 billion. The semiconductors materials are mainly dominated by companies…
Semiconductor Die Attach Materials Market: Size, Revenue Share, Insights & Futur …
Semiconductor Die Attach Materials - Market Size
The global market for Semiconductor Die Attach Materials was estimated to be worth US$ 496.9 million in 2023 and is forecast to a readjusted size of US$ 681.5 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030
Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-2N10351/Global_Semiconductor_Die_Attach_Materials_Market_Insights_Forecast_to_2028?utm_source=Openpr&utm_medium=Referral
Typical die-attach materials are PbSn, PbSnAg or PbInAg alloys. These alloys wet conventional substrates and die metallizations due to the formation…
Through Silicon Via (TSV) Equipment Market Size, Revenue Share, Insights & Futur …
Through Silicon Via (TSV) Equipment Market
Through silicon via (TSV) is a vertical interconnection technology that penetrates silicon wafers or chips. It achieves fully perforated vertical electrical connections between chips, between chips and wafers, and between wafers by drilling tiny holes (via) on silicon wafers and filling them with conductive materials (such as copper, polysilicon, tungsten, etc.). The basic structure of TSV includes two metal shells (i.e., upper metal and lower…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
